{
  "actions": [
    {
      "acted_at": "1986-08-15", 
      "committee": "Committee on Labor and Human Resources", 
      "references": [], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on Labor and Human Resources.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "s2772-99", 
  "bill_type": "s", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "Senate Labor and Human Resources", 
      "committee_id": "SSHR"
    }
  ], 
  "congress": "99", 
  "cosponsors": [], 
  "enacted_as": null, 
  "history": {
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "1986-08-15", 
  "number": "2772", 
  "official_title": "A bill to amend the Orphan Drug Act of the Food, Drug and Cosmetic Act to allow more than one company to be granted a seven year exclusive marketing privilege due to simultaneous development when more than one company has filed a New Drug Application (NDA) before the time the first company has received FDA approval for its product.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Orphan Drug Amendments of 1986", 
  "sponsor": {
    "district": null, 
    "name": "Hatch, Orrin G.", 
    "state": "UT", 
    "thomas_id": "01351", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "1986-08-15", 
  "subjects": [
    "Drug safety and regulation", 
    "Drugs", 
    "Drugs and narcotics", 
    "Research"
  ], 
  "subjects_top_term": "Drugs", 
  "summary": {
    "as": "Introduced", 
    "date": "1986-08-15", 
    "text": "Orphan Drug Amendments of 1986 - Amends the Federal Food, Drug, and Cosmetic Act to permit more than one seven year exclusive marketing privilege for an orphan drug when simultaneous development has resulted in more than one company filing a new drug application before the first company receives Federal approval for its drug."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "title": "Orphan Drug Amendments of 1986", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "title": "A bill to amend the Orphan Drug Act of the Food, Drug and Cosmetic Act to allow more than one company to be granted a seven year exclusive marketing privilege due to simultaneous development when more than one company has filed a New Drug Application (NDA) before the time the first company has received FDA approval for its product.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-02-02T19:56:01-05:00"
}